Current
$450M
5-Year Average
$89.1M
All-Time High
$649M
All-Time Low
$1.47M
Market cap daily chart for Relmada Therapeutics (RLMD)
Jul 28, 2021 – Jul 27, 2026 · 1,254 trading days
Market Cap growth chart for Relmada Therapeutics (RLMD) from 2018 to 2026
Latest: +136.1%
Market Cap history table for Relmada Therapeutics (RLMD) from 2015 to 2026
| 2026 | $450M | +136.1% | +$260M | ||
| 2025 | $191M | +1115.7% | +$175M | ||
| 2024 | $15.7M | -49.4% | -$15.3M | ||
| 2023 | $31M | +19.9% | +$5.15M | ||
| 2022 | $25.9M | -67.3% | -$53.3M | ||
| 2021 | $79.2M | -20.8% | -$20.8M | ||
| 2020 | $100M | +38.9% | +$28M | ||
| 2019 | $72M | +2740.9% | +$69.5M | ||
| 2019 | $9.34M | +268.7% | +$6.81M | ||
| 2018 | $2.53M | +27.9% | +$553K | ||
| 2017 | $1.98M | -62.5% | -$3.3M | ||
| 2016 | $5.28M | -73.8% | -$14.9M | ||
| 2015 | $20.2M | — | — |
- 2026$450M+136.1%
- 2025$191M+1115.7%
- 2024$15.7M-49.4%
- 2023$31M+19.9%
- 2022$25.9M-67.3%
- 2021$79.2M-20.8%
- 2020$100M+38.9%
- 2019$72M+2740.9%
- 2019$9.34M+268.7%
- 2018$2.53M+27.9%
- 2017$1.98M-62.5%
- 2016$5.28M-73.8%
- 2015$20.2M—
Market Cap values are taken from Relmada Therapeutics's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Relmada Therapeutics (RLMD)
According to Relmada Therapeutics's latest reported financial statements, the company's latest reported market cap is $603M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Relmada Therapeutics (RLMD) came in at $450M – surged 136.1% year-over-year.
Over 2021–2026 (5 years), Relmada Therapeutics market cap expanded at a +41.6% compound annual rate, sustaining 2 straight years of year-over-year growth.
2026 marks the peak market cap at $450M, with the historical low of $1.98M recorded in 2017.
Relmada Therapeutics Market Cap by Year
Relmada Therapeutics Market Cap 2026: $450M
Relmada Therapeutics posted market cap of $450M in 2026, surged 136.1% from 2025. This figure represents the highest annual value in the available history.
Relmada Therapeutics Market Cap 2025: $191M
In 2025, Relmada Therapeutics reported market cap of $191M, surged 1115.7% from 2024.
Relmada Therapeutics Market Cap 2024: $15.7M
Relmada Therapeutics market cap in 2024 was $15.7M, plunged 49.4% below 2023.
Relmada Therapeutics Market Cap 2023: $31M
2023's market cap for Relmada Therapeutics came in at $31M, grew 19.9% from 2022.
Relmada Therapeutics Market Cap 2022: $25.9M
Relmada Therapeutics market cap in 2022 was $25.9M.
See more financial history for Relmada Therapeutics (RLMD).
Sector peers by Market Cap
Healthcare peers of Relmada Therapeutics (RLMD), ranked by their latest market cap
| $1.13T | |
| $640B | |
| $454B | |
| $379B | |
| $323B | |
| $221B | |
| $208B | |
| $203B |
- $1.13T
- $454B
- $323B
- $221B
- $203B
Frequently asked questions
Test yourself on RLMD
Market Cap — 10 rounds, every one of them RLMD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Relmada Therapeutics (RLMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.